Skip to content

Clinical trials

Pulmonary Eosinophilia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20114
20121
20131
20143
20152
20164
20177
20185
20198
202013
202113
202210
202311
20248
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Unknown status21
Recruiting8
Active, not recruiting8
Not yet recruiting7
Terminated7
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca17
GlaxoSmithKline9
Teva Branded Pharmaceutical Products R&D, Inc.5
Areteia Therapeutics4
Hospices Civils de Lyon3
University Hospital Southampton NHS Foundation Trust3
Advagene Biopharma Co. Ltd.2
Aristotle University Of Thessaloniki2
Chiesi Farmaceutici S.p.A.2
McMaster University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia103
Asthma57
Churg-Strauss Syndrome4
Lung Diseases3
Airway Remodeling2
Eosinophilia2
Hypereosinophilic Syndrome2
Inflammation2
Nasal Polyps2
Pulmonary Disease, Chronic Obstructive2

Trials

Showing 76 to 100 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.